Since PUFA is elevated and ELOVL5 expression is upregulated in NE-like PCa cells (Figure 1), we wanted to know whether ELOVL5-mediated fatty acid elongation contributes to enzalutamide resistance. Here, ELOVL5 is linked to posterior cortical atrophy.